Tumefactive Demyelinating Disease Treated with Decompressive Craniectomy
Overview
Affiliations
Background: Tumefactive demyelinating disease (TDD) is a rare primary demyelinating disease with diagnostic and therapeutic challenges.
Methods And Results: We report a 50-year old woman with TDD successfully treated with decompressive craniectomy and corticosteroids. The patient presented with seizures, subacute progressive hemispheric syndrome, and a tumourlike abnormality on MRI. Demyelinating disease was initially considered unlikely. Due to a rapidly evolving herniation syndrome hemicraniectomy was performed. Outcome was favourable with only very mild neurological deficits 6 weeks later.
Conclusion: TDD should be considered as a differential diagnosis in tumour-like presentations, and appears to have distinctive neuroimaging features. In the advent of treatement failure from high dose corticosteroids and plasmapheresis and development of severe mass effect, decompressive hemicraniectomy is an important treatment option.
Ide T, Ebashi R, Eriguchi M, Aishima S, Abe T, Hara H Clin Case Rep. 2024; 12(7):e9059.
PMID: 38988893 PMC: 11233259. DOI: 10.1002/ccr3.9059.
Management of Recurrent Tumefactive Multiple Sclerosis: Case Report and Literature Review.
Rissardo J, Caprara A Asian J Neurosurg. 2018; 13(3):893-896.
PMID: 30283576 PMC: 6159023. DOI: 10.4103/ajns.AJNS_94_18.
Chin Med J (Engl). 2017; 130(15):1838-1850.
PMID: 28748858 PMC: 5547837. DOI: 10.4103/0366-6999.211547.
Kebir S, Gaertner F, Mueller M, Nelles M, Simon M, Schafer N Oncol Lett. 2016; 11(3):2195-2198.
PMID: 26998148 PMC: 4774557. DOI: 10.3892/ol.2016.4189.
Granget E, Milh M, Pech-Gourg G, Paut O, Girard N, Lena G Childs Nerv Syst. 2012; 28(7):1121-4.
PMID: 22399246 DOI: 10.1007/s00381-012-1733-9.